Literature DB >> 10974955

Obstetric complications and schizophrenia. Two case-control studies based on structured obstetric records.

R E Kendell1, K McInneny, E Juszczak, M Bain.   

Abstract

BACKGROUND: Most previous case-control studies of obstetric complications in schizophrenia have been small scale and many have relied on retrospective information. AIMS: To determine which obstetric complications are more common in probands with schizophrenia than matched controls.
METHOD: Two hundred and ninety-six probands with an in-patient diagnosis of schizophrenia who had been born in Scotland in 1971-74, and a further 156 born in 1975-78, were closely matched with controls and the incidence of obstetric complications in the two compared using obstetric data recorded in a set format shortly after birth.
RESULTS: Not a single complication of pregnancy or delivery was significantly more common in the probands with schizophrenia than the controls in the 1971-74 birth cohort and only emergency Caesarean section and labour lasting over 12 hours were significantly more common in the schizophrenia probands in the 1975-78 cohort.
CONCLUSION: The evidence that schizophrenia is associated with a raised incidence of obstetric complications is weaker than has recently been assumed.

Entities:  

Mesh:

Year:  2000        PMID: 10974955     DOI: 10.1192/bjp.176.6.516

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  11 in total

Review 1.  Recent advances in the genetics of schizophrenia.

Authors:  D M Waterwort; A S Bassett; L M Brzustowicz
Journal:  Cell Mol Life Sci       Date:  2002-02       Impact factor: 9.261

Review 2.  Preeclampsia and Neurodevelopmental Outcomes: Potential Pathogenic Roles for Inflammation and Oxidative Stress?

Authors:  Aaron Barron; Cathal M McCarthy; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2021-01-25       Impact factor: 5.590

Review 3.  What risk factors tell us about the causes of schizophrenia and related psychoses.

Authors:  J Kelly; R M Murray
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

Review 4.  Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophrenia.

Authors:  Christina G S Palmer
Journal:  J Biomed Biotechnol       Date:  2010-04-06

5.  Does consanguinity increase the risk of schizophrenia? Study based on primary health care centre visits.

Authors:  Abdulbari Bener; Elnour E Dafeeah; Nancy Samson
Journal:  Ment Health Fam Med       Date:  2012-12

Review 6.  Developmental precursors of psychosis.

Authors:  Matti Isohanni; Irene Isohanni; Hannu Koponen; Johanna Koskinen; Pekka Laine; Erika Lauronen; Jouko Miettunen; Pirjo Mäki; Kaisa Riala; Sami Räsänen; Kaisa Saari; Pekka Tienari; Juha Veijola; Graham Murray
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

7.  Postmaturity in a genetic subtype of schizophrenia.

Authors:  E W C Chow; J Husted; R Weksberg; A S Bassett
Journal:  Acta Psychiatr Scand       Date:  2003-10       Impact factor: 6.392

8.  A plausible model of schizophrenia must incorporate psychological and social, as well as neuro developmental, risk factors.

Authors:  E Bramon; R M Murray
Journal:  Dialogues Clin Neurosci       Date:  2001-12       Impact factor: 5.986

9.  Effect of Rhesus D incompatibility on schizophrenia depends on offspring sex.

Authors:  Christina G S Palmer; Erin Mallery; Joni A Turunen; Hsin-Ju Hsieh; Leena Peltonen; Jouko Lonnqvist; J Arthur Woodward; Janet S Sinsheimer
Journal:  Schizophr Res       Date:  2008-08-09       Impact factor: 4.939

Review 10.  Common or distinct pathways to psychosis? A systematic review of evidence from prospective studies for developmental risk factors and antecedents of the schizophrenia spectrum disorders and affective psychoses.

Authors:  Kristin R Laurens; Luming Luo; Sandra L Matheson; Vaughan J Carr; Alessandra Raudino; Felicity Harris; Melissa J Green
Journal:  BMC Psychiatry       Date:  2015-08-25       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.